Integra LifeSciences Holdings (IART)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 348 |
| % of all portfolios: | 0.016% |
| Hold Price * : | $25.09 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 9,419 | 0.01 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 26.02% | 2,627 | 0.00 | |
| Q2 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.60% | 61 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Reduce 2.17% | 1,000 | 0.01 | |
| Q1 2022 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Reduce 6.67% | 3,000 | 0.02 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 7,007 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Robert Olstein - Olstein Capital Management | Reduce 10.87% | 5,000 | 0.04 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 68.58% | 15,292 | 0.02 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 24.83% | 3,254 | 0.00 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 37.27% | 7,786 | 0.01 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.